Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-30

Clinical Trial Update: Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of Conbercept for diabetic macular edema in patients with severe non-proliferative diabetic ret…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Conbercept (conbercept)

Snippet

Sponsor: Shanghai Eye Disease Prevention and Treatment Center | Conditions: Diabetic Macular Edema | Phase 4 | Status: ACTIVE_NOT_RECRUITING